author-photo

Ana Kostic

Celgene

3

Papers

79

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas

2019 Blood
Show All
- Source
- Cite
- Save
Citations (70)
Outpatient Treatment with Lisocabtagene Maraleucel (liso-cel) in Three Ongoing Clinical Studies in Relapsed/Refractory (R/R) B Cell Non-Hodgkin Lymphoma (NHL), Including Second-Line Transplant Ineligible Patients: Transcend NHL 001, Outreach, and PILOT

2019 Blood
Show All
- Source
- Cite
- Save
Citations (9)